69 results
DRS
EX-4.3
STRO
Sutro Biopharma Inc
1 Jun 18
Draft registration statement
12:00am
of the Securities Act, the availability of which depends upon, among other things, the bona fide nature of the investment intent and the accuracy … that it is capable of evaluating the merits and risks of its investment in the Company and protecting its own interests.
(d) Speculative Nature
DRS
EX-4.5
STRO
Sutro Biopharma Inc
1 Jun 18
Draft registration statement
12:00am
of which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Holder’s representations as expressed herein … and risks of its investment in the Company and protecting its own interests.
(d) Speculative Nature of Investment. The Holder understands
8-K
EX-99.1
snmnl s1eek9
2 Apr 24
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
6:04am
S-8
EX-99.1
dehi5
31 Aug 22
Registration of securities for employees
4:32pm
S-8
EX-99.1
tqyl0dzz3n7znyje8n0
9 Aug 21
Registration of securities for employees
12:00am
8-K
EX-99.1
x8kbj i5xb9iqopi
21 Nov 23
Departure of Directors or Certain Officers
4:05pm
DRS
EX-10.9
kfabo boz4
1 Jun 18
Draft registration statement
12:00am
DRS
EX-4.6
91hkl8j9la
1 Jun 18
Draft registration statement
12:00am
D
uch6 due46jvq
6 Jun 18
$60M in equity, sold $31.62M, 8 investors
3:50pm
UPLOAD
85g3ymxl
29 Jun 18
Letter from SEC
12:00am
D/A
rjmr1tu7d
8 Aug 18
$85.38M in equity, sold $85.38M, 15 investors
9:57am